{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:08:54Z","timestamp":1787843334713,"version":"build-2784847793"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Hematologic malignancies (HM) impose substantial healthcare and productivity-related costs globally. However, disparities in economic impact across regions and countries remain insufficiently explored. This study aimed to evaluate the global, regional, and national economic burden of HM and its subtypes (leukemia, non-Hodgkin lymphoma, multiple myeloma, and Hodgkin lymphoma) from 1990 to 2021, with projections to 2050.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Data from the Global Burden of Disease 2021 study were utilized to estimate the economic burden of HM using the value of a statistical life year (VSLY) approach, based on disability-adjusted life years (DALYs). Decomposition analysis was conducted to identify drivers of economic burden, including population growth and aging. Future trends were modeled using the Bayesian Age-Period-Cohort (BAPC) model, and comparisons of economic burden were made across countries by income levels.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In 2021, the global economic burden of HM reached $1.516 trillion, a 52.8% increase from $992 billion in 1990. This represented approximately 1% of the global GDP, with high-income countries (HICs) bearing the largest share of 2.17% of GDP, compared to 0.58% in lower-middle-income countries (LMICs). The United States had the highest national burden at $417.42 billion (95% UI: $389.49\u2013$435.80 billion), followed by China $133.84 billion (95% UI: $98.63\u2013$166.21 billion), $113.03 billion (95% UI: $101.62\u2013$122.88 billion), and Japan $88.30 billion (95% UI: $85.65\u2013$90.24 billion). By 2050, the global burden is projected to decline to $1.249 trillion, driven by healthcare advancements in HICs, but with a rising burden in upper-middle-income countries (UMICs), which are expected to account for 48.1% of the global burden. China is projected to lead globally with $421.65 billion (95% UI: $314.68\u2013$1,495.35 billion), followed by India ($123.8 billion), while the United States is expected to decline to $101.6 billion. Subtype-specific analysis revealed that Leukemia accounted for the largest proportion of the burden in 2021 ($651 billion, 42.9%), followed by NHL ($492 billion, 32.5%), multiple myeloma ($278.17 billion, 100.5%), and Hodgkin lymphoma ($43.84 billion, 21%).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The economic burden of HM has increased significantly, with marked disparities across regions and income levels. By 2050, the burden is expected to shift from high- to middle-income countries. Investments in early diagnosis, affordable treatments, and healthcare improvements are essential to reduce the burden and address inequities.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2025.1570792","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T05:32:20Z","timestamp":1751002340000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Global, regional, and national economic burden of hematologic malignancies (1990\u20132021) with projections to 2050"],"prefix":"10.3389","volume":"13","author":[{"given":"Zhexian","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangpeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guibin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1001\/jamaoncol.2018.2706","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016: a systematic analysis for the Global Burden of Disease Study","volume":"4","author":"Fitzmaurice","year":"2018","journal-title":"JAMA Oncol."},{"key":"B2","unstructured":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues\n          \n          2025"},{"key":"B3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin."},{"key":"B4","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1001\/jamaoncol.2022.7826","article-title":"Estimates and projections of the global economic cost of 29 cancers in 204 countries and territories from 2020 to 2050","volume":"9","author":"Chen","year":"2023","journal-title":"JAMA Oncol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/S1470-2045(11)70141-3","article-title":"Delivering affordable cancer care in high-income countries","volume":"12","author":"Sullivan","year":"2011","journal-title":"Lancet Oncol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41408-020-0323-4","article-title":"Changes in long term survival after diagnosis with common hematologic malignancies in the early 21st century","volume":"10","author":"Pulte","year":"2020","journal-title":"Blood Cancer J."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/S0140-6736(17)32513-8","article-title":"Alleviating the access abyss in palliative care and pain relief-an imperative of universal health coverage: the Lancet Commission report","volume":"391","author":"Knaul","year":"2018","journal-title":"Lancet."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.jval.2024.04.004","article-title":"Economic evaluations of chimeric antigen receptor T-cell therapies for hematologic and solid malignancies: a systematic review","volume":"27","author":"Thavorn","year":"2024","journal-title":"Value Health."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","article-title":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e1715","DOI":"10.1016\/S2214-109X(22)00429-6","article-title":"Assessing performance of the Healthcare Access and Quality Index, overall and by select age groups, for 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019","volume":"10","year":"2022","journal-title":"Lancet Glob Health"},{"key":"B12","doi-asserted-by":"publisher","first-page":"101580","DOI":"10.1016\/j.eclinm.2022.101580","article-title":"Global and regional projections of the economic burden of Alzheimer's disease and related dementias from 2019 to 2050: a value of statistical life approach","volume":"51","author":"Nandi","year":"2022","journal-title":"EClinicalMedicine."},{"key":"B13","unstructured":"United\n              Nations\n            \n          \n          World Population Prospects - Population Division\n          \n          2025"},{"key":"B14","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12874-020-01133-5","article-title":"An R package for an integrated evaluation of statistical approaches to cancer incidence projection","volume":"20","author":"Knoll","year":"2020","journal-title":"BMC Med Res Methodol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jare.2023.07.003","article-title":"Temporal trends of breast cancer burden in the Western Pacific Region from 1990 to 2044: implications from the Global Burden of Disease Study 2019","volume":"59","author":"Wu","year":"","journal-title":"J Adv Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10888-011-9214-z","article-title":"Decomposition procedures for distributional analysis: a unified framework based on the Shapley value","volume":"11","author":"Shorrocks","year":"2013","journal-title":"J Econ Inequal."},{"key":"B17","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1017\/bca.2017.21","article-title":"Best estimate selection bias in the value of a statistical life","volume":"9","author":"Viscusi","year":"2018","journal-title":"J Benefit-Cost Analy."},{"key":"B18","unstructured":"CPI\n              Home\n            \n          \n          Bureau of Labor Statistics\n          \n          2025"},{"key":"B19","unstructured":"Guidelines\n              For Regulatory Impact Analysis\n            \n          \n          ASPE\n          \n          2017"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.4015886","article-title":"Reference case guidelines for benefit-cost analysis in global health and development","author":"Robinson","year":"2019","journal-title":"SSRN J."},{"key":"B21","unstructured":"DataBank\n          \n          \n          \n          2025"},{"key":"B22","unstructured":"World Bank Country and Lending Groups - World Bank Data Help Desk\n          \n          2025"},{"key":"B23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1017\/bca.2018.26","article-title":"Valuing mortality risk reductions in global benefit-cost analysis","volume":"10","author":"Robinson","year":"2019","journal-title":"J Benefit Cost Anal."},{"key":"B24","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1017\/bca.2017.12","article-title":"Income elasticities and global values of a statistical life","volume":"8","author":"Viscusi","year":"2017","journal-title":"J Benefit-Cost Analy."},{"key":"B25","volume-title":"Standardization and Decomposition of Rates: A User's Manual","author":"Das Gupta","year":"1993"},{"key":"B26","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0140-6736(17)30818-8","article-title":"Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: a novel analysis from the Global Burden of Disease Study 2015","volume":"390","year":"2017","journal-title":"Lancet"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1570792\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T05:32:21Z","timestamp":1751002341000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1570792\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,27]]},"references-count":26,"alternative-id":["10.3389\/fpubh.2025.1570792"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2025.1570792","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,27]]},"article-number":"1570792"}}